Skip to main content

Table 3 Proportion of dogs showing Flea Allergy Dermatitis signs at the initial visit and 12 week recheck following treatment with either topical fluralaner or a positive control

From: A randomized, blinded, controlled USA field study to assess the use of fluralaner topical solution in controlling canine flea infestations

Sign

 

Fluralaner topical solution

Fipronil/(S)-methoprene spot-on solution

Erythema

Number of dogs with sign at initial exam that were also eligible for re-examination at 12 weeks

58

25

% of dogs with lesion resolved at 12-week re-examination

91.4

60.0

Alopecia

Number of dogs with sign at initial exam that were also eligible for re-examination at 12 weeks

43

19

% of dogs with lesion resolved at 12-week re-examination

86.0

78.9

Papules

Number of dogs with sign at initial exam that were also eligible for re–examination at 12 weeks

32

6

% of eligible dogs with lesion resolved at 12-week re-examination

96.9

100.0

Scales

Number of dogs with sign at initial exam that were also eligible for re-examination at 12 weeks

27

11

% of eligible dogs with lesion resolved at 12-week re-examination

92.6

72.7

Crusts

Number of dogs with sign at initial exam that were also eligible for re-examination at 12 weeks

28

10

% of eligible dogs with lesion resolved at 12-week re-examination

100.0

80.0

Excoriation

Number of dogs with sign at initial exam that were also eligible for re-examination at 12 weeks

25

6

% of eligible dogs with lesion resolved at 12-week re-examination

100.0

83.3